✦ LIBER ✦

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

✍ Scribed by Reetta Kälviäinen; Martin J Brodie; John Duncan; David Chadwick; David Edwards; Karsten Lyby

Book ID: 108460497
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 95 KB
Volume: 30
Category: Article
ISSN: 0920-1211
DOI: 10.1016/s0920-1211(97)00082-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter Double-Blind, Randomized, Pl

Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures

✍ Simon D. Shorvon; Armand Löwenthal; Dieter Janz; Edith Bielen; Pierre Loiseau; f 📂 Article 📅 2000 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 672 KB

Multicenter double-blind, randomized, pl

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures

✍ Xun-Yi Wu; Zhen Hong; Xun Wu; Li-Wen Wu; Xue-Feng Wang; Dong Zhou; Zhong-Xin Zha 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 381 KB

Gabapentin as Add-On Therapy in Children

Gabapentin as Add-On Therapy in Children with Refractory Partial Seizures: A 12-Week, Multicentre, Double-Blind, Placebo-Controlled Study

✍ Richard Appleton; Klaus Fichtner; Linda LaMoreaux; Jeannine Alexander; Gwyneth H 📂 Article 📅 1999 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 671 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures

✍ Victor Biton; Gregory Krauss; Blanca Vasquez-Santana; Francesco Bibbiani; Alliso 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 222 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

A double-blind, placebo-controlled evalu

A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures

✍ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u